Develop Anti-Aging Interventions
The Challenge
Aging is the leading risk factor for chronic diseases and functional decline.
For innovators, developing interventions that genuinely extend healthspan and delay age-related decline remains one of the most complex challenges.
Current pre-clinical models are lacking translational value, or are too slow, expensive, and ethically constrained, making it difficult to generate robust, translational evidence.
Key trends
By 2050, 1 in 6 people globally will be over 65, driving demand for validated longevity and healthy aging solutions.
Over 90% of drug candidates fail in late-stage development due to poor early-stage predictivity.
There is a pressing need for innovative solutions that provide fast, reliable, and ethically sound insights into how compounds impact biological age, healthspan, and lifespan.
With such platforms, companies can accelerate innovation, reduce risks, and bring differentiated interventions to the market with confidence.
Automated in vivo results at the in vitro scale:
fast, ethical, and translational solutions
Translational in vivo Model
Access a proven in vivo model that speaks the same biological language as human aging. Using C. elegans, we help you rapidly identify compounds that impact healthspan and longevity — ethically, reproducibly, and with direct translational relevance.
End-to-End Automation and Insights
You focus on discovery; we take care of the rest. Our automated workflow covers design, execution, and analysis — turning complex data into clear biological meaning. Get results you can trust, and move from screening to decision with confidence.
High Throughput, Reduced Costs
Run hundreds of conditions in parallel to screen for biological age, healthspan, and lifespan effects simultaneously. Reduce time, cost, and variability — so you can focus resources on the interventions most likely to deliver real impact in humans.
The Swiss Knife Solution for Healthy Aging Discoveries
Nagi™ C-Age
High-throughput in vivo measurement of lifespan and motility.
Multidimensional insights in a single assay.
Nagi™ B-Age
AI-powered in vivo biological age and healthspan measurement to fast-track your innovation in just 10 days.
Dissect the mechanism of action among 5 vital traits.
Recent Projects
With Nagi Bioscience, you gain:
Validated, data-backed claims
to differentiate your nutraceutical or therapeutic product in a crowded market.
Biological Age readouts in as little as 10 days
enabling rapid go/no-go decisions.
Scalable testing capacity
that accelerates your R&D timelines.
Reduced ethical and financial burden
by minimizing reliance on vertebrate studies until later stages.
Confidence in innovation
with robust mechanistic insights to support efficacy, safety, and translational value.
From discovery to proof-of-concept to lead optimization and IND preparation, we empower you to bring longer, healthier lives within reach.
“We are very pleased with Nagi Bioscience. Their innovative technology has been instrumental in allowing us to gather critical scientific data quickly, providing invaluable insights that significantly advance our research in longevity.“
“Their services revealed new insights and opened up exciting possibilities for exploring the potential of our strains in health applications related to healthy aging, helping us advance our research further.“
“Their high-throughput approach provided clear, quantifiable insights into the lifespan and functional effects of our lead combinations— critical data that helped de-risk and prioritize our therapeutic strategy.“